FDA Adverse Event Injury Summary report: N

3.7MM TI CERVICAL SPINE SCREW SLF-DRLG/VARIABLE ANGLE 14MM

MDR report key: 2971315 · Received February 21, 2013

Report

Report Number
8030965-2013-00569
Event Type
Injury
Date Received
February 21, 2013
Date of Event
January 24, 2013
Report Date
January 24, 2013
Manufacturer
SYNTHES GMBH
Product Code
OVE
PMA / PMN Number
K112068
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MN
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE MANUFACTURING DOCUMENTS WERE REVIEWED AND NO COMPLAINT RELATED ISSUES WERE FOUND. THE DEVICE WAS RETURNED AND THE INVESTIGATION IS ONGOING.

Additional Manufacturer Narrative · 1

DEVICE IS USED FOR TREATMENT, NOT DIAGNOSIS. NO VISIBLE DAMAGES, EXCEPT SOME SLIGHT STRESS MARKS AT THE SCREW HEAD, WHICH WERE CAUSED DURING THE INSERTION. A FUNCTION TEST WAS PERFORMED AND THE SCREW DID LOCK IN PLACE IN THE IMPLANT AS REQUIRED. NO MANUFACTURING RELATED FAULT COULD BE DETECTED. AFTER ASSEMBLING THE 2 SCREWS INTO THE IMPLANT, IT WAS NOTED THAT THE BLOCKING MECHANISM IS IN GOOD WORKING CONDITION. THERE DOES NOT SEEM TO BE ANY DESIGN RELATED ISSUES WITH THIS IMPLANT. IT IS POSSIBLE THAT EITHER SOFT TISSUE WAS INTERFERING WITH THE SCREW INSERTION AND/OR BLOCKING MECHANISM OR POSSIBLY IMPROPER SURGICAL TECHNIQUE.

Description of Event or Problem · 1

DURING A ACDF C6, C7 SPINE SURGERY, SURGEON INSERTED 2 SCREWS INTO THE INTERBODY PLATE OF THE ZERO P IMPLANT AND THE SECURING MECHANISM WOULD NOT ENGAGE ON ONE OF THE SCREWS. SURGEON REMOVED BOTH SCREWS AND PLATE PER SYNTHES TECHNIQUE GUIDE. SURGEON CHOSE ANOTHER SAME SIZE PLATE AND 2 LONGER LENGTH SCREWS TO IMPLANT. DUE TO THE REMOVAL AND IMPLANTING OF THE PLATE AND SCREWS, SURGERY WAS EXTENDED AN EXTRA 15 MINUTES. THIS IS 2 OF 3 REPORTS FOR THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
76709 3.7MM TI CERVICAL SPINE SCREW SLF-DRLG/VARIABLE ANGLE 14MM CERVICAL SPINE SCREW OVE SYNTHES GMBH 7984093

Patients

Seq Age Sex Outcome Treatment
1 32 YR Required Intervention